Nerven Pharma (NGEN) makes public offering at 2.50/share
I'm holding a fairly larger position in the company at $5.18 ACB. I believe in the eventual marketing of the drug, but the PO is making me queasy. If you didn't see it, they made a public offering to of 24 Million common shares and warrants at $2.50/share. For seemingly good reasons: advance of the nvg-291 drug through clinical studies, working capital for their corporate processes, etc. Stock way down 40 % overnight as you might expect, and opened at $2.05.
So the question is - would it be considered good strategy to sell my existing shares at about 10-11am when the dust settles - and then buy back after the 30-day wash period is over? I suspect it's going to give existing investors the jitters, while offering an opportunities to new investors, if they wish to avail themselves of it.
But I do even see a scenario with the the price being even lower if I want to buy back in around 7/1/26 . What would you all do? Sell them now, buy back in...or just sit tight on shares and see what develops. I probably have a patience threshold for about 1-2 years on this one to see where it's headed.
My first time though one of these : (